Serina Therapeutics Announces Completion of Enrollment in the Phase Ia Trial of SER-214 in Parkinson’s Disease Read More
Serina Therapeutics Announces President and CEO will Speak at the Upcoming BIO CEO and Investor Conference in New York February 13 Read More
Serina Therapeutics Announces Publication of Invited Feature Article in European Polymer Journal Read More
Serina Therapeutics Announces President and CEO will Deliver Invited Lecture on POZ Therapeutics at Annual American Chemical Society Meeting in Philadelphia Read More
Serina Therapeutics Announces Advancing to Multi-Dose Phase in Parkinson’s Disease Patients in the SER-214 Phase I Trial Read More